Patient characteristics
| Patient characteristic . | n (%) . | Patients with DLBCL N = 29 n (%) . | Patients with FL N = 5 n (%) . |
|---|---|---|---|
| Age, median (range) | 74 (28-87) | ||
| Sex | |||
| Male | 17 (50) | 15 (51) | 2 (40) |
| Female | 17 (50) | 14 (48) | 3 (60) |
| Histology | |||
| FL | 5 (14) | ||
| DLBCL | 29 (85) | ||
| GCB | 18 (62) | ||
| Non-GCB | 8 (27) | ||
| EBV | 1 (3) | ||
| Unknown (not reported) | 2 (7) | ||
| Ann Arbor stage | |||
| II | 4 (14) | 1 (20) | |
| III | 5 (17) | 2 (40) | |
| IV | 20 (69) | 2 (40) | |
| B symptoms | 4 (12) | 4 (14) | 0 (0) |
| Extranodal disease | 23 (68) | 23 (80) | 0 (0) |
| LDH elevated | 22 (65) | 20 (70) | 2 (40) |
| Prior treatment lines | |||
| 1 | 10 (29) | 6 (21) | 4 (80) |
| 2 | 6 (17) | 6 (21) | 0 (0) |
| 3+ | 18 (53) | 17 (58) | 1 (20) |
| Prior treatment details | |||
| Chemotherapy/R-chemotherapy | 34 (100) | 29 (100) | 5 (100) |
| Immunotherapy | 0 (0) | 0 (0) | 0 (0) |
| Bispecific therapy | 4 (12) | 3 (10) | 1 (20) |
| CAR T cell | 3 (9) | 3 (10) | 0 (0) |
| Other | |||
| Autologous stem cell transplant | 1 (3) | 1 (3) | 0 (0) |
| Patient characteristic . | n (%) . | Patients with DLBCL N = 29 n (%) . | Patients with FL N = 5 n (%) . |
|---|---|---|---|
| Age, median (range) | 74 (28-87) | ||
| Sex | |||
| Male | 17 (50) | 15 (51) | 2 (40) |
| Female | 17 (50) | 14 (48) | 3 (60) |
| Histology | |||
| FL | 5 (14) | ||
| DLBCL | 29 (85) | ||
| GCB | 18 (62) | ||
| Non-GCB | 8 (27) | ||
| EBV | 1 (3) | ||
| Unknown (not reported) | 2 (7) | ||
| Ann Arbor stage | |||
| II | 4 (14) | 1 (20) | |
| III | 5 (17) | 2 (40) | |
| IV | 20 (69) | 2 (40) | |
| B symptoms | 4 (12) | 4 (14) | 0 (0) |
| Extranodal disease | 23 (68) | 23 (80) | 0 (0) |
| LDH elevated | 22 (65) | 20 (70) | 2 (40) |
| Prior treatment lines | |||
| 1 | 10 (29) | 6 (21) | 4 (80) |
| 2 | 6 (17) | 6 (21) | 0 (0) |
| 3+ | 18 (53) | 17 (58) | 1 (20) |
| Prior treatment details | |||
| Chemotherapy/R-chemotherapy | 34 (100) | 29 (100) | 5 (100) |
| Immunotherapy | 0 (0) | 0 (0) | 0 (0) |
| Bispecific therapy | 4 (12) | 3 (10) | 1 (20) |
| CAR T cell | 3 (9) | 3 (10) | 0 (0) |
| Other | |||
| Autologous stem cell transplant | 1 (3) | 1 (3) | 0 (0) |
CAR, chimeric antigen receptor; EBV, Epstein-Barr virus; GCB, germinal center B-cell-like; LDH, lactate dehydrogenase.